直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Prosecution First Blog

Om-what’s-man Program? USPTO’s Ombudsman Program

December 15, 2016

Authored and Edited by Adriana L. Burgy; Stephanie M. Sanders

The USPTO’s Patents Ombudsman program is available to help applicants before, during, and after the patent examination process.  The Patents Ombudsman program initially started as a pilot program in April 2010 and now is an established program supported by the USPTO.  The program ensures that an applicant, attorney, or agent gets the assistance they need when the normal channels have not yielded that assistance.

The Patents Ombudsman program does not take over prosecution of an application and does not collect data concerning particular patent examiners.  Instead, their focus is on the application process and applications that get stalled in the process.  Common issues where an Ombudsman may be of assistance include applicant status inquires, filing questions, application prosecution concerns, provisional applications, and general questions such as clarity and consistency of examination practice.

Each technology center (TC) has an Ombudsman and to contact one for a specific application, there is an electronic form for submission on the USPTO’s website.  According to the program websiteone can expect to receive a call from the TC Ombudsman representative concerning the request for assistance within one business day.  With the installation of the regional offices, service hours are from 8:30 AM to 8:00 PM ET.  The Patents Ombudsman can be contacted at 855.559.8589 (toll free) or 571.272.555 or by email at OmbudsmanProgram@uspto.gov.

Since its inception in 2010, the number of inquiries has exponentially increased.  For example, in 2011, the program fielded about 372 total inquiries and in 2015, the program fielded about 4,859 total inquiries.  The Patents Ombudsman program focuses on the process and is not pro-Office or pro-customer.  It is not a replacement for an Appeal or Petition and is best utilized when there is a bottleneck in the prosecution process.

On Tuesday, October 11, 2016, the Patents Ombudsman program was the subject of a 2016 Patent Quality Chat.  The slide presentation and video from that chat are posted on the USPTO’s website under the 2016 Patent Quality Chats and can be accessed here.

Tags

patent application, Patents Ombudsman, patent quality

Contacts

Adriana L. Burgy
Partner
Washington, DC
+1 202 408 4345
Email

Copyright © 2016 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Lecture

IPIC/McGill Summer IP Course 2026: Understanding Trademarks

July 14, 2026

Montreal

Charitable

Bridges From School to Work Gala 2026

June 22, 2026

Washington, DC

Lecture

Munich Licensing Summer Course 2026

June 18-19, 2026

Munich

Conference

2026 Copyright Society Annual Meeting

June 14-16, 2026

Louisville

Conference

17th Summit on Biosimilars & Innovator Biologics

June 2-3, 2026

New York

Articles

Colorado Replaces Landmark AI Act: An Overview of the New SB 26-189 Framework

May 26, 2026

At the PTAB Blog

IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026

May 26, 2026

Conference

BIA Start-up Festival

May 21, 2026

London

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP